<snip>...Roche executives met with investors and analysts Tuesday in New York to further explain the rationale for taking Genentech private and to defend their $89-a-share offer. Roche executives were to meet with Genentech management, including CEO Art Levinson, on Tuesday night.The consensus appears to be that Roche will have to raise the offer to make the deal work."Minority shareholders want to be treated fairly; $89 a share is not fair value,"...</snip>from: http://www.thestreet.com/story/10429721/4/what-now-genentech...
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma